494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses

494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses

Bibliographic Details
Main Authors:	Peter Probst, Kevin Green, Huyen Dinh, Francisco Zapata, Darbie Whitman, Tom Graddis, Meghan Zuck, Ray Fox, Myriam N Bouchlaka, Tatyana Pisarenko, Elsa L Hay, Gajendra Naika, Jacob Heit, Kamal D Puri
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

519 OR641 is a novel dual antagonist antibody that targets LILRB1 and LILRB2 inhibitory receptors and promotes a Th1-like immune response
by: Peter Probst, et al.
Published: (2023-11-01)

575 Preclinical characterization of LAE111, a potent anti-LILRB1/LILRB2 antagonist bispecific antibody
by: Rong Wu, et al.
Published: (2023-11-01)

1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models
by: Yi Xu, et al.
Published: (2023-11-01)

LILRB4, an immune checkpoint on myeloid cells
by: Ting Yang, et al.
Published: (2022-04-01)

Placental Malaria is Associated with Higher LILRB2 Expression in Monocyte Subsets and Lower Anti-Malarial IgG Antibodies During Infancy
by: Celia Dechavanne, et al.
Published: (2022-07-01)

Molecular regulatory mechanism of LILRB4 in the immune response
by: Haiyin Liu, et al.
Published: (2023-02-01)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
by: Harrison, TE, et al.
Published: (2020)

LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
by: Zhiqing Xiang, et al.
Published: (2024-02-01)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
by: Qiyuan Zhuang, et al.
Published: (2023-10-01)

518 Discovery of MACO-355, a novel, first in mechanism ligand-blocking independent anti-LILRB1/2 monoclonal antibody for cancer therapy
by: Luca Cassetta, et al.
Published: (2023-11-01)

501 AZD2796, a myeloid checkpoint inhibitor targeting LILRB2 that promotes pro-inflammatory responses by macrophages and enhances T cell anti-tumor activity
by: Simon Dovedi, et al.
Published: (2023-11-01)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
by: Giles, J, et al.
Published: (2010)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
by: Dan-Pei Li, et al.
Published: (2023-07-01)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
by: Tobias Zeller, et al.
Published: (2023-09-01)

LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
by: Peng Zhao, et al.
Published: (2022-06-01)

494 Expert group decision making for pharmacogenomic testing in Ontario
by: Samuel Neumark, et al.
Published: (2024-04-01)

494 DYSPAREUNIA ONE YEAR POSTPARTUM. A HIDDEN BURDEN?
by: R Zachariah, et al.
Published: (2022-06-01)

<i>HLA-G</i>, <i>LILRB1</i> and <i>LILRB2</i> Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil
by: Amarilis Giaretta de Moraes, et al.
Published: (2022-06-01)

The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.
by: Young, N, et al.
Published: (2008)

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
by: Yeboah, Muchaala, et al.
Published: (2021)

BZT 494-3 - BIOLOGI AMPHIBIA & REPTILIA OKT-NOV 1991.
by: PPSKJ, Pusat Pengajian Sains Kajihayat
Published: (1991)

Linoleic Acid Upregulates Microrna-494 to Induce Quiescence in Colorectal Cancer
by: Ruiko Ogata, et al.
Published: (2021-12-01)

MiRNA-494 induces trophoblast senescence by targeting SIRT1
by: Sha Su, et al.
Published: (2023-12-01)

BZT 494-3 - BIOLOGI AMPHIBIA & REPTILIA OKT-NOV 1990.pdf
by: PPSKJ, Pusat Pengajian Sains Kajihayat
Published: (1990)

BZT 494-3 - BIOLOGI AMPHIBIA & REPTILIA OKT-NOV 1991.pdf
by: PPSKJ, Pusat Pengajian Sains Kajihayat (School of Biological Sciences)
Published: (1991)

P494: Hypermobility EDS: Successful implementation of a referral screening program
by: Jaime Vengoechea, et al.
Published: (2024-01-01)

Fatal Cronobacter sakazakii Sequence Type 494 Meningitis in a Newborn, Brazil
by: Cláudia Elizabeth Volpe Chaves, et al.
Published: (2018-10-01)

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
by: Courtney Dinardo, et al.
Published: (2023-08-01)

Characterization of the Leucocyte Immunoglobulin-like Receptor B4 (<i>Lilrb4</i>) Expression in Microglia
by: Felix Kretzschmar, et al.
Published: (2021-12-01)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
by: Renheng Zou, et al.
Published: (2023-05-01)

A LILRB1 variant with a decreased ability to phosphorylate SHP-1 leads to autoimmune diseases
by: Thivaratana Sinthuwiwat, et al.
Published: (2022-09-01)

Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure
by: Ee Von Woon, et al.
Published: (2023-01-01)

Decidual Macrophage Functional Polarization during Abnormal Pregnancy due to Toxoplasma gondii: Role for LILRB4
by: Zhidan Li, et al.
Published: (2017-08-01)

Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses.
by: Myriam N Bouchlaka, et al.
Published: (2012-01-01)

Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer
by: Sakiko Kumata, et al.
Published: (2023-07-01)

MicroRNA-377 Alleviates Myocardial Injury Induced by Hypoxia/Reoxygenation via Downregulating LILRB2 Expression
by: Mengwei Xie, et al.
Published: (2020-06-01)

Identification of the hybrid gene LILRB5-3 by long-read sequencing and implication of its novel signaling function
by: Hirayasu, Kouyuki, et al.
Published: (2024)

The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
by: Xiaohui Wang, et al.
Published: (2023-09-01)

Response to comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema
by: Sashwanthi Mohan, et al.
Published: (2022-01-01)

P494: An analysis of ALPL gene variants in patients with hypophosphatasia from the Global Hypophosphatasia Registry
by: Priya Kishnani, et al.
Published: (2023-01-01)